Skip to main content

Advertisement

SpringerLink
Log in

Serum pepsinogen I levels of gastric ulcer patients are determined by the location of the ulcer crater

  • Alimentary Tract
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

To examine the relation between gastric ulcer (GU) location and serum pepsinogen I (PGI) level, we measured this marker in 284 endoscopically proved GU patients. Their ulcer locations were further divided according to Johnson’s criteria modified to the corpus (type la), gastric angle (type lb), combined with duodenal ulcer (type 2) and prepyloric area (type 3). The numbers of each subset were 96, 81, 58 and 49, respectively. Mean serum PGI level (99.6 ± 44.8 ng/ml) of all GU patients showed no difference from that of their sex and age matched controls. Mean serum PGI levels in both type la and lb patients, did not differ from each other but were significantly lower than in controls, in contrast to those in type 2 and 3 patients which were significantly higher than in controls and comparable to the PGI levels of patients with duodenal ulcer. Smoking did not affect mean serum PGI levels in all subsets except the smoking type 2 patients who manifested a significantly higher mean PGI level. Helicobacter pylori infection did not show different serum PGI levels in any subset. In conclusion, different location of ulcer in the stomach results in a characteristic serum PGI level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615–625.

    PubMed  CAS  Google Scholar 

  2. Samloff IM: Peptic ulcer: the many proteinases of aggression. Gastroenterology 1989;96:586–595.

    PubMed  CAS  Google Scholar 

  3. Albillos A, Alvarez-Mon M, Rossi I, et al: Different HCL and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets. Am J Gastroenterol 1990;85:535–538.

    PubMed  CAS  Google Scholar 

  4. Samloff IM, Liebman WM, Panitch NM: Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975;69:83–90.

    PubMed  CAS  Google Scholar 

  5. Kirk RM: Are gastric and duodenal ulcers separate diseases or do they form a continuum? Dig Dis Sci 1981; 26:149–154.

    Article  PubMed  CAS  Google Scholar 

  6. Rotter JI: Gastric and duodenal ulcer are each many different diseases. Dig Dis Sci 1981;26:154–160.

    Article  PubMed  CAS  Google Scholar 

  7. Kang JY: Age of onset of symptoms in duodenal and gastric ulcer. Gut1990;31:854–857.

    Article  PubMed  CAS  Google Scholar 

  8. Mcintosh JH, Byth K, Piper DW: Environmental factors in etiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut1985:26:78–798.

    Article  Google Scholar 

  9. Thomas J, Greig M, Mcintosh J, et al: The location of chronic gastric ulcer. Digestion 1980;20;79–84.

    Article  PubMed  CAS  Google Scholar 

  10. Johnson HD; Gastric ulcer: Classification, blood group characteristics, secretion patterns and pathogenesis. Ann Surg 1965;162: 996–1004.

    Article  PubMed  CAS  Google Scholar 

  11. Vianello F, Plebani M, Piccoli A, et al: Role of serum pepsinogen in detecting ulcer disease. Clin Chim Acta 1988:172:335–340.

    Article  PubMed  CAS  Google Scholar 

  12. Huang SC, Miki K, Furihata C, et al: Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies-with data on peptic ulcer and gastric ulcer. Clin Chim Acta1988:175:37–50.

    Article  PubMed  CAS  Google Scholar 

  13. Basson M, Modlin IM: Pepsinogen: biological and pathophysiologic significance. J Surg Res 1988:44:82–97.

    Article  PubMed  CAS  Google Scholar 

  14. Chang FY, Lai KH, Lu LC, et al: The relationships between Campylobacter pylori and inflammatory cell infiltration of antral mucosa in patients with dyspepsia. J Formosan Med Assoc 1989:80:8–12.

    Google Scholar 

  15. Brazer SR, Tyor MP, Pancotto FS, et al: Studies of gastric ulcer disease by community based gastroenterologists. Am J Gastroenterol 1990:85:824–828.

    PubMed  CAS  Google Scholar 

  16. Basson MD, Modlin IM: Pepsinogen. J Clin Gastroenterol 1987;9: 475–479.

    Article  PubMed  CAS  Google Scholar 

  17. Ichinose M, Miki K, Furihata C, et al: Radioimmunoassay of serum group I and II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982;126:183–191.

    Article  PubMed  CAS  Google Scholar 

  18. Samloff IM, Stemmermann GN, Heilbrun LK, et al: Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986;90:570–575.

    PubMed  CAS  Google Scholar 

  19. Richardson CT: Role of aggressive factors in the pathogenesis of peptic ulcer disease. Scand J Gastroenterol 1990;25(suppl 174):37–43.

    Article  Google Scholar 

  20. Card WI, Marks IN: The relationship between the acid output of the stomach following “maximal” histamine stimulation and the parietal cell mass. Clin Sci 1960;19:147–163.

    PubMed  CAS  Google Scholar 

  21. Ruding R: Gastric ulcer and antral border. Surgery 1967;61:495–497.

    PubMed  CAS  Google Scholar 

  22. Baron JH: An assessment of the augmented histamine test in the diagnosis of peptic ulcer. Gut 1963;4:243–253.

    Article  PubMed  CAS  Google Scholar 

  23. Tatsuta M, Ishi H, Okuda S: Location of peptic ulcers in relation to antral and fundal gastritis by chromoendoscopic follow-up examinations. Dig Dis Sci 1986;31:7–11.

    Article  PubMed  CAS  Google Scholar 

  24. Stadelmann O, Elster K, Stolte M, et al: The peptic gastric ulcerhistopographic and functional investigations. Scand J Gastroenterol 1971:6:613–623.

    Article  PubMed  CAS  Google Scholar 

  25. Samloff IM, Varis K, Ihamaki T, et al: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982:83:204–209.

    PubMed  CAS  Google Scholar 

  26. Malesci A, Basilico M, Bersani M, et al: Serum pepsinogen I elevation in cigarette smokers. Scand J Gastroenterol 1988;23:602–606.

    Article  PubMed  CAS  Google Scholar 

  27. Miki K, Ichinose M, Shimizu A, et al: Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987:22:133–141.

    PubMed  CAS  Google Scholar 

  28. Miki K, Ichinose M, Kawamura N, et al: The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111–114.

    PubMed  CAS  Google Scholar 

  29. Gear NML, Truelove SC, Whitehead R: Gastric ulcer and gastritis. Gut1971;12:639–645.

    Article  PubMed  Google Scholar 

  30. Lam SK, Lai CL: Gastric ulcers with and without associated duodenal ulcer have different pathophysiology. Clin Sci Mol Med 1978;55:97–102.

    PubMed  CAS  Google Scholar 

  31. Eastwood GL: The role of smoking in peptic ulcer disease. J Clin Gastroenterol 1988;10(Suppl):S19-S23.

    Article  PubMed  Google Scholar 

  32. Boyd EJS, Wilson JA, Wormsley KG: Smoking impairs therapeutic gastric inhibition. Lancet 1983;l:95–97.

    Article  Google Scholar 

  33. Allen A, Pearson JP, Blackburn A, et al: Pepsins and the mucus barrier in peptic ulcer disease. Scand J Gastroenterol 1988;23(Suppl 146):50–57.

    Article  Google Scholar 

  34. Walker V, Taylor WH: Cigarette smoking, chronic peptic ulceration and pepsin 1 secretion. Gut 1979;20:971–976.

    Article  PubMed  CAS  Google Scholar 

  35. Parente F, Lazzaroni M, Sangaletti O, et al: Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut 1985;26:1327–1332.

    Article  PubMed  CAS  Google Scholar 

  36. Rademaker JW, Hunt RH: Acid and barriers, current research and future developments for peptic ulcer therapy. Scand J Gastroenterol 1990;25(suppl 175):19–26.

    Article  Google Scholar 

  37. Yeomans ND: Bacteria in ulcer pathogenesis. Bailliere’s Clin Gastroenterol 1988;2:573–591.

    Article  CAS  Google Scholar 

  38. Korman MG: Helicobacter pylori: fact or fiction? Scand J Gastroenterol 1990;25(suppl 175): 159–165.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, Veterans General Hospital-Taipei, 201 Shin-Pai Road, Section 2, 11217, Taipei, Taiwan

    Full-Young Chang M.D., Kwok-Hung Lai, Te-Fong Wang, Fa-Yau Lee, Shou-Dong Lee & Yang-Te Tsai

Authors
  1. Full-Young Chang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kwok-Hung Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Te-Fong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fa-Yau Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shou-Dong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yang-Te Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, FY., Lai, KH., Wang, TF. et al. Serum pepsinogen I levels of gastric ulcer patients are determined by the location of the ulcer crater. Gastroenterol Jpn 27, 9–14 (1992). https://doi.org/10.1007/BF02775058

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02775058

Key Words

Search

Navigation